Delivery Order SPE2DB25D3012-SPE2DB25FXALG
- Not listed
- The Defense Logistics Agency awarded a $1,861.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Briviact 25 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Briviact 100mg tablets (60 count) with a ceiling value of $2,786.04. This is a firm fixed-price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, with a ceiling value of $2,859.99. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 20, 2025. This delivery order...
- The Defense Logistics Agency awarded a $3,168.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of September 15, 2025. The award, issued on September 12, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $5,576.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, and performance location in Conshohocken, Pennsylvania, where the contractor maintains its corporate office. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a $1,044.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,145.77 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Briviact 75 mg tablets (60 count) with a contract value of $7,826.28. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of August 28, 2025, and performance will take place at the awardee's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXALGDelivery Order
The Defense Logistics Agency awarded a $13.48K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for 60 tablets of Briviact 50 mg, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1.0B through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, fulfills this order as part of its comprehensive pharmaceutical supply mission supporting military and veteran healthcare systems. The company's IDC vehicle enables it to supply a broad range of pharmaceutical products and medical supplies globally to support Defense Health Agency requirements and other federal healthcare systems. This delivery order for Briviact, a psychiatric medication, exemplifies the specialized pharmaceutical commodities distributed through AmerisourceBergen's federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 9/24/25 |